Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China - Chen, Nan; Qian, Jiaqi; Chen, Jianghua; Yu, Xueqing; Mei, Changlin; Hao, Chuanming; Jiang, Gengru; Lin, Hongli; Zhang, Xinzhou; Zuo, Li; He, Qiang; Fu, Ping; et al. (Nephrology, dialysis, transplantation, 2017)
Keywords: Adolescent; Adult; Aged; Aged, 80 and over; Anemia - drug therapy; Anemia - etiology; Cohort Studies; Double-Blind Method; Female; Glycine - analogs & derivatives; Glycine - therapeutic use; Humans; Hypoxia-Inducible Factor-Proline Dioxygenases - antagonists & inhibitors; Isoquinolines - therapeutic use; Male; Middle Aged; Original; Renal Dialysis; Renal Insufficiency, Chronic - complications; Young Adult; FG-4592; hypoxia-inducible factor; erythropoiesis; anemia in chronic kidney disease; erythropoietin